Adenosine monophosphate-activated protein kinase (AMPK) as a target for antidiabetic drugs.

A. Gruzman, Gali Babai, Shlomo Sasson

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Adenosine monophosphate-activated protein kinase (AMPK) as a target for antidiabetic drugs.'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology